XML 28 R20.htm IDEA: XBRL DOCUMENT v3.25.1
Related Party Transactions
3 Months Ended
Mar. 31, 2025
Related Party Transactions [Abstract]  
Related Party Transactions

13. Related Party Transactions

As of March 31, 2025 and December 31, 2024, the Company was obligated to pay Amgen $6.3 million and nil, respectively, under the Amgen Collaboration Agreement, which was recorded within current liabilities on the condensed consolidated balance sheets. During the three months ended March 31, 2025 and 2024, the Company recorded $6.3 million and nil, respectively, of research and development expenses with Amgen.